GlassScriptPhysician profile
Andrew Pridjian
NPI 1033552799
$10,192.36
in general payments reported to CMS, 2019-2025
33 companies · $688 in 2025
The $688 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $396 · 2021: $919 · 2022: $2,811 · 2023: $4,853 · 2024: $253 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $1,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $1,294.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,083.37 | 2022-2023 | Da Vinci Sp, Da Vinci Surgical System |
| Teleflex LLC | $756.51 | 2020-2024 | Urolift |
| Astellas Pharma US INC | $357.16 | 2019-2025 | Xtandi, Myrbetriq |
| Edap Technomed INC | $223.54 | 2025 | |
| Boston Scientific Corporation | $204.53 | 2021-2024 | Greenlight Xps |
| Mesh Suture INC | $181.88 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $125.53 | 2019 | |
| Abc Home Medical Supply, INC. | $120.25 | 2022-2024 | |
| Axonics, INC. | $108.79 | 2020-2023 | Bulkamid |
| Procept Biorobotics Corporation | $106.66 | 2023-2025 | Aquabeam Robotic System |
| Sumitomo Pharma America, INC. | $103.07 | 2023-2025 | Gemtesa |
| Neotract INC. | $86.75 | 2020 | |
| Medtronic USA, INC. | $81.43 | 2019 | |
| Blue Earth Diagnostics | $79.63 | 2021 | |
| Medtronic, INC. | $70.78 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $56.47 | 2024-2025 | Aveed, Xiaflex |
| Endo Pharmaceuticals INC. | $56.16 | 2021-2023 | Xiaflex, Aveed |
| Profound Medical Corp. | $47.60 | 2025 | Tulsa-Pro |
| Baxter Healthcare | $42.60 | 2023-2025 | Perclot, Floseal |
| Abbvie INC. | $38.26 | 2022-2024 | |
| Urovant Sciences INC | $31.74 | 2022 | |
| Mission Pharmacal Company | $29.41 | 2022 | |
| Dendreon Pharmaceuticals LLC | $28.22 | 2024 | Provenge |
| Pacira Pharmaceuticals Incorporated | $24.25 | 2024 | Iovera, Exparel |
| Innovation Technologies INC | $24.15 | 2025 | Irrisept |
| Civco Medical Instruments | $23.90 | 2024 | |
| 180 Medical, INC. | $22.05 | 2022 | |
| Coloplast Corp | $15.55 | 2023 | Titan |
| Astrazeneca Pharmaceuticals LP | $15.18 | 2024 | Lynparza |
| Olympus America INC. | $14.70 | 2024 | Itind System |
| Angiodynamics, INC. | $13.12 | 2023 | Nanoknife |
| Richard Wolf Medical Instruments Corp. | $12.81 | 2023 | |
| Travere Therapeutics, INC. | $6.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Pridjian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.